CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenue	$ 60,801	$ 47,516	$ 117,111	$ 89,830
Costs and expenses:
Cost of revenue	11,330	8,491	21,549	16,063
Research and development	21,656	12,942	39,354	25,092
Marketing and sales	3,431	2,979	6,339	5,735
General and administrative	5,609	2,663	8,222	4,943
Total costs and expenses	42,026	27,075	75,464	51,833
Income (loss) from operations	18,775	20,441	41,647	37,997
Interest and other income (expense), net	(19)	93	(1,139)	919
Income before income taxes	18,756	20,534	40,508	38,916
Provision (benefit) for income taxes	2,908	2,197	(2,113)	3,935
Net income	$ 15,848	$ 18,337	$ 42,621	$ 34,981
Earnings per share:
Basic (in dollars per share)	$ 6.23	$ 7.28	$ 16.79	$ 13.87
Diluted (in dollars per share)	$ 6.18	$ 7.14	$ 16.62	$ 13.56
Weighted-average shares used to compute earnings per share:
Basic (in shares)	2,543	2,518	2,538	2,522
Diluted (in shares)	2,566	2,570	2,565	2,580

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities
Net income	$ 42,621	$ 34,981
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	12,355	8,242
Share-based compensation	13,690	8,981
Deferred income taxes	1,568	(2,163)
Unrealized loss on equity investments	1,185	320
Other	(73)	(376)
Changes in assets and liabilities:
Accounts receivable	(2,273)	1,466
Prepaid expenses and other current assets	(3,230)	686
Other assets	(2,535)	(242)
Accounts payable	(354)	(574)
Accrued expenses and other current liabilities	5,662	(3,338)
Other liabilities	(4,528)	1,604
Net cash provided by operating activities	64,088	49,587
Cash flows from investing activities
Purchases of property and equipment	(49,113)	(29,479)
Purchases of marketable securities	(75,592)	(19,509)
Sales and maturities of marketable securities	44,036	19,057
Purchases of non-marketable equity investments	(1,670)	(15,214)
Payments for held-for-sale assets	(674)	(775)
Acquisitions of businesses and intangible assets	(474)	(62)
Other investing activities	156	14
Net cash used in investing activities	(83,331)	(45,968)
Cash flows from financing activities
Taxes paid related to net share settlement of equity awards	(8,704)	(8,993)
Repurchases of Class A common stock	0	(22,921)
Payments for dividends and dividend equivalents	(2,699)	(2,656)
Proceeds from issuance of long-term debt, net	24,910	0
Principal payments on finance leases	(1,805)	(1,225)
Other financing activities	(2,288)	323
Net cash provided by (used in) financing activities	9,414	(35,472)
Effect of exchange rate changes on cash, cash equivalents, restricted cash, and restricted cash equivalents	0	243
Net decrease in cash, cash equivalents, restricted cash, and restricted cash equivalents	(9,829)	(31,610)
Cash, cash equivalents, restricted cash, and restricted cash equivalents at beginning of the period	39,100	45,438
Cash, cash equivalents, restricted cash, and restricted cash equivalents at end of the period	29,271	13,828
Reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents to the condensed consolidated balance sheets
Cash and cash equivalents	15,462	12,005
Restricted cash and restricted cash equivalents, included in prepaid expenses and other current assets	702	161
Restricted cash and restricted cash equivalents, included in other assets	13,107	1,662
Total cash, cash equivalents, restricted cash, and restricted cash equivalents	29,271	13,828
Supplemental cash flow data
Cash paid for income taxes, net	1,999	5,544
Cash paid for interest, net of amounts capitalized	1,097	478
Non-cash investing and financing activities:
Property and equipment in accounts payable and accrued expenses and other current liabilities	19,502	10,618
Acquisition of businesses and intangible assets in accounts payable, accrued expenses and other current liabilities, and other liabilities	2,172	132
Non-marketable equity investments in accrued expenses and other current liabilities	0	651
Repurchases of Class A common stock in accrued expenses and other current liabilities	$ 0	$ 131

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 15,462	$ 35,873
Marketable securities	74,798	45,719
Accounts receivable, net	21,752	19,769
Prepaid expenses and other current assets	13,463	7,361
Total current assets	125,475	108,722
Non-marketable equity investments	30,157	27,524
Property and equipment, net	225,724	176,400
Operating lease right-of-use assets	23,985	20,404
Goodwill	23,406	24,534
Other assets	21,209	8,437
Total assets	449,956	366,021
Current liabilities:
Accounts payable	15,889	8,894
Operating lease liabilities, current	2,425	2,213
Accrued expenses and other current liabilities	38,065	30,729
Total current liabilities	56,379	41,836
Operating lease liabilities, non-current	26,229	22,940
Long-term debt	83,664	58,744
Long-term income taxes	18,326	21,005
Other liabilities	4,137	4,253
Total liabilities	188,735	148,778
Commitments and contingencies
Stockholders' equity:
Common stock and additional paid-in capital	103,981	95,793
Accumulated other comprehensive income (loss)	(603)	271
Retained earnings	157,843	121,179
Total stockholders' equity	261,221	217,243
Total liabilities and stockholders' equity	$ 449,956	$ 366,021